Treatment for people with cholangiocarcinoma at Mayo Clinic Nov. 18, 2014 Overview Show transcript Overview Hepatobiliary surgeon Rory L. Smoot, M.D., discusses the risk factors, presenting symptoms, diagnosis and development of a multidisciplinary care approach for patients with cholangiocarcinoma — cancer of the bile tubes or bile ducts of the liver. Related ContentArticlePemigatinib trial seeks to build on targeted advances in cholangiocarcinomaArticleScientific and clinical advances aid in diagnosis, staging and treatment of cholangiocarcinoma VID-20433357 Medical Professionals Treatment for Patients With Cholangiocarcinoma at Mayo Clinic